Circulating ICAM-1 as a Marker for Behçet's Disease
Author Information
Author(s): K. Hamzaoui, A. Chabbou, K. Ayed
Primary Institution: Faculté de Médecine de Tunis
Hypothesis
Is circulating intercellular adhesion molecule-1 (cICAM-1) a reliable marker for the inflammatory process in patients with active Behçet's disease?
Conclusion
Circulating ICAM-1 levels are significantly elevated in patients with active Behçet's disease compared to healthy controls and those in remission.
Supporting Evidence
- ICAM-1 levels were significantly higher in patients with active Behçet's disease compared to healthy controls.
- Patients with active tuberculosis also showed elevated ICAM-1 levels, similar to those with active Behçet's disease.
- ICAM-1 may serve as a useful marker for disease activity in Behçet's disease.
Takeaway
This study found that a substance in the blood called ICAM-1 is higher in people with active Behçet's disease, which might help doctors understand how active the disease is.
Methodology
The study measured circulating ICAM-1 levels in serum and bronchoalveolar lavage fluid using an enzyme-linked immunosorbent assay (ELISA).
Potential Biases
Potential bias due to the selection of control groups and the lack of treatment for patients.
Limitations
The study did not include a diverse demographic or long-term follow-up of patients.
Participant Demographics
40 patients with Behçet's disease, including 28 in active stage and 12 in remission, compared to healthy controls and tuberculosis patients.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website